about
Adverse Effects of GLP-1 Receptor AgonistsDoes combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?Dapagliflozin in patients with type 2 diabetes mellitus.The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].Safety considerations with fenofibrate/simvastatin combination.Acid-base and electrolyte disorders associated with the use of antidiabetic drugs.Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversies.
P2860
Q26801346-3F6EEA9F-5CCA-4A10-818C-14B394974A58Q33776187-E8A12290-41C2-483A-8E0A-97E139D2FA11Q35064363-4D832A38-E53D-4FA9-BE22-A7DE4796AAD4Q38205588-59B2C5FB-BC95-4C4F-B9BC-D8AD7A28427DQ38541832-44CA2E58-3CF0-40A2-91CC-0B4A46BB2216Q38658251-CB049089-07D2-41D2-A917-059EFAB2A5A5Q39000587-47BAC7A9-ECE5-4E5F-9991-C5E3072B236C
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Combination drug treatment in obese diabetic patients
@ast
Combination drug treatment in obese diabetic patients
@en
Combination drug treatment in obese diabetic patients
@nl
type
label
Combination drug treatment in obese diabetic patients
@ast
Combination drug treatment in obese diabetic patients
@en
Combination drug treatment in obese diabetic patients
@nl
prefLabel
Combination drug treatment in obese diabetic patients
@ast
Combination drug treatment in obese diabetic patients
@en
Combination drug treatment in obese diabetic patients
@nl
P2860
P356
P1476
Combination drug treatment in obese diabetic patients
@en
P2860
P356
10.4239/WJD.V1.I1.8
P577
2010-03-01T00:00:00Z